Specific therapies proposed for the management of COVID-19
Copyright: © 2020 Revista Medica del Instituto Mexicano del Seguro Social..
The appearance of a new coronavirus, which has caused the collapse of health systems around the world, has led to the emergence of numerous investigations looking for the ideal treatment and proper management of this new entity, since its control has become impossible and its cure an international necessity. To date, there are hundreds of articles and clinical trials to review. For this reason, in an attempt to facilitate the reader's knowledge of the new evidence and in summary form, the different therapies studied so far are presented in this article: their antiviral and adverse effects. Without forgetting that there are still doubts to be resolved and this process of new knowledge is just beginning.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:58 |
|---|---|
| Enthalten in: |
Revista medica del Instituto Mexicano del Seguro Social - 58(2020), Supl 2 vom: 21. Sept., Seite S229-237 |
| Sprache: |
Spanisch |
|---|
| Weiterer Titel: |
Terapias específicas propuestas para el manejo de COVID-19 |
|---|
| Beteiligte Personen: |
Olvera-Reyes, Oscar [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Coronavirus Infections |
|---|
| Anmerkungen: |
Date Revised 27.10.2021 published: Print Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.24875/RMIMSS.M20000134 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM332354164 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM332354164 | ||
| 003 | DE-627 | ||
| 005 | 20231225215412.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||spa c | ||
| 024 | 7 | |a 10.24875/RMIMSS.M20000134 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1107.xml |
| 035 | |a (DE-627)NLM332354164 | ||
| 035 | |a (NLM)34695335 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a spa | ||
| 100 | 1 | |a Olvera-Reyes, Oscar |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Specific therapies proposed for the management of COVID-19 |
| 246 | 3 | 3 | |a Terapias específicas propuestas para el manejo de COVID-19 |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 27.10.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Copyright: © 2020 Revista Medica del Instituto Mexicano del Seguro Social. | ||
| 520 | |a The appearance of a new coronavirus, which has caused the collapse of health systems around the world, has led to the emergence of numerous investigations looking for the ideal treatment and proper management of this new entity, since its control has become impossible and its cure an international necessity. To date, there are hundreds of articles and clinical trials to review. For this reason, in an attempt to facilitate the reader's knowledge of the new evidence and in summary form, the different therapies studied so far are presented in this article: their antiviral and adverse effects. Without forgetting that there are still doubts to be resolved and this process of new knowledge is just beginning | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Coronavirus Infections | |
| 650 | 4 | |a Dexamethasone | |
| 650 | 4 | |a Drug Therapy | |
| 650 | 4 | |a Pandemics | |
| 650 | 4 | |a SARS-CoV-2 | |
| 700 | 1 | |a Ábrego-Lara, J Jesús Horacio |e verfasserin |4 aut | |
| 700 | 1 | |a Rodríguez-Hernández, Gregorio Iván |e verfasserin |4 aut | |
| 700 | 1 | |a Bazán-Muñoz, Oscar Daniel |e verfasserin |4 aut | |
| 700 | 1 | |a Trujillo-Rodríguez, César Aurelio |e verfasserin |4 aut | |
| 700 | 1 | |a Gómez-Limón, Livier |e verfasserin |4 aut | |
| 700 | 1 | |a Castellón-Lomelí, Chrystian Irán |e verfasserin |4 aut | |
| 700 | 1 | |a Íñiguez-Venegas, Valeria Judith |e verfasserin |4 aut | |
| 700 | 1 | |a Martínez-González, Edith Livier |e verfasserin |4 aut | |
| 700 | 1 | |a Martínez-Tavarez, Juan Francisco |e verfasserin |4 aut | |
| 700 | 1 | |a Ramírez-Ramos, Manuel |e verfasserin |4 aut | |
| 700 | 1 | |a Santoscoy-Aguirre, Pablo Salvador |e verfasserin |4 aut | |
| 700 | 1 | |a Vásquez-Ramos, Juan Emilio |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Revista medica del Instituto Mexicano del Seguro Social |d 2005 |g 58(2020), Supl 2 vom: 21. Sept., Seite S229-237 |w (DE-627)NLM156363798 |x 0443-5117 |7 nnns |
| 773 | 1 | 8 | |g volume:58 |g year:2020 |g number:Supl 2 |g day:21 |g month:09 |g pages:S229-237 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.24875/RMIMSS.M20000134 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 58 |j 2020 |e Supl 2 |b 21 |c 09 |h S229-237 | ||